Atlas Trials

A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

Clinical trial NCT06454240 · COMPLETED

Trial details

NCT number
NCT06454240
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Rhinosinusitis With Nasal Polyps
Start date
2024-07-17
Primary completion
2026-01-29
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.